These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4578947)

  • 21. Behavioral effects of thyrotropin releasing hormone in animals and man: a generic hypothesis.
    Prange AJ; Wilson IC
    Psychopharmacol Bull; 1975 Jan; 11(1):22-4. PubMed ID: 804704
    [No Abstract]   [Full Text] [Related]  

  • 22. The amino acid sequence of a peptide with growth hormone-releasing activity isolated from porcine hypothalamus.
    Schally AV; Baba Y; Nair RM; Bennett CD
    J Biol Chem; 1971 Nov; 246(21):6647-50. PubMed ID: 4943678
    [No Abstract]   [Full Text] [Related]  

  • 23. Structure of the porcine LH- and FSH-releasing hormone. II. Confirmation of the proposed structure by conventional sequential analyses.
    Baba Y; Matsuo H; Schally AV
    Biochem Biophys Res Commun; 1971 Jul; 44(2):459-63. PubMed ID: 4946067
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hypothalamic releasing and inhibiting hormones].
    Vanha-Perttula T
    Duodecim; 1973 Oct; 20(1):1282-98. PubMed ID: 4361282
    [No Abstract]   [Full Text] [Related]  

  • 25. Biosynthesis of hypothalamic hypophysiotropic factors.
    Reichlin S; Mitnick M
    Front Neuroendocrinol; 1973; 0(0):61-88. PubMed ID: 4137560
    [No Abstract]   [Full Text] [Related]  

  • 26. Letter: Lithium and M.R.I.H. in tardive dyskinesia.
    Ehrensing RH
    Lancet; 1974 Dec; 2(7894):1459-60. PubMed ID: 4140382
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative MSH release-inhibiting activities of tocinoic acid (the ring of oxytocin), and L-pro-L-leu-gly-NH 2 (the side chain of oxytocin).
    Bower A; Hadley ME; Hruby VJ
    Biochem Biophys Res Commun; 1971 Dec; 45(5):1185-91. PubMed ID: 5135504
    [No Abstract]   [Full Text] [Related]  

  • 28. DOPA potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF).
    Plotnikoff NP; Kastin AJ; Anderson MS; Schally AV
    Life Sci I; 1971 Nov; 10(22):1279-83. PubMed ID: 4947365
    [No Abstract]   [Full Text] [Related]  

  • 29. 3 H-labelling of a synthetic decapeptide having LH and FSH releasing activity (LH-RH--FSH-RH).
    Marche P; Morgat JL; Fromageot P; Kerdelhue B; Jutisz M
    FEBS Lett; 1972 Oct; 26(1):83-6. PubMed ID: 4564663
    [No Abstract]   [Full Text] [Related]  

  • 30. Melanocyte-stimulating hormone-release inhibiting hormone as a antidepressant. A pilot study.
    Ehrensing RH; Kastin AJ
    Arch Gen Psychiatry; 1974 Jan; 30(1):63-5. PubMed ID: 4587068
    [No Abstract]   [Full Text] [Related]  

  • 31. Evidence that Pro-Leu-Gly-NH 2 , tocinoic acid, and des-Cys-tocinoic acid do not affect secretion of melanocyte stimulating hormone.
    Grant NH; Clark DE; Rosanoff EI
    Biochem Biophys Res Commun; 1973 Mar; 51(1):100-6. PubMed ID: 4540644
    [No Abstract]   [Full Text] [Related]  

  • 32. Electrophysiological correlates of melanocyte-stimulating hormone activity in the frog.
    Denman PM; Miller LH; Sandman CA; Schally AV; Kastin AJ
    J Comp Physiol Psychol; 1972 Jul; 80(1):59-65. PubMed ID: 4557920
    [No Abstract]   [Full Text] [Related]  

  • 33. Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF) (LH-hypothalamus-LRF-gas chromatography-mass spectrometry-decapeptide-Edman degradation).
    Burgus R; Butcher M; Amoss M; Ling N; Monahan M; Rivier J; Fellows R; Blackwell R; Vale W; Guillemin R
    Proc Natl Acad Sci U S A; 1972 Jan; 69(1):278-82. PubMed ID: 4550508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melanocyte-stimulating hormone and parkinsonism: the role of hypothalamic releasing factors.
    Sandler M; Goodwin BL; Leask BG; Ruthven CR
    Lancet; 1973 Mar; 1(7803):612. PubMed ID: 4120682
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chemistry of the "releasing" hormones. History and latest developments].
    Boler J
    Tidsskr Nor Laegeforen; 1972 Nov; 92(32):2154-60. PubMed ID: 4632739
    [No Abstract]   [Full Text] [Related]  

  • 36. Chemistry of the hypothalamic releasing factors--studies on structure-function relationships.
    Vale W; Grant G; Guillemin R
    Front Neuroendocrinol; 1973; 0(0):375-413. PubMed ID: 4369859
    [No Abstract]   [Full Text] [Related]  

  • 37. Distribution, half-life, and excretion of 14 C- and 3 H-labeled L-prolyl-L-leucyl-glycinamide in the rat.
    Redding TW; Kastin AJ; Nair RM; Schally AV
    Neuroendocrinology; 1973; 11(2):92-100. PubMed ID: 4697489
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypothalamic regulatory hormones.
    Schally AV; Coy DH; Meyers CA
    Annu Rev Biochem; 1978; 47():89-128. PubMed ID: 28075
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hypothalamic releasing hormones. I. Structure, sources of formation, physiologic effects].
    Dedov II; Dedov VI
    Usp Sovrem Biol; 1980; 89(1):141-58. PubMed ID: 6104883
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hypophysiotropic factors, hypothalamus "hormone"].
    Smelik PG
    Ned Tijdschr Geneeskd; 1975 Aug; 119(32):1240-6. PubMed ID: 238160
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.